speb/financial-data huggingface dataset:
AXP.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 4042000000.00
AXP.TO balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 4042000000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 4042000000.00
AXP.TO balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 4042000000.00
AXP.TO income_statement (annual, 2024-12-31) — Normalized Income: 9808516711.90
AXP.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 14050000000.00
AXP.TO income_statement (annual, 2024-12-31) — Operating Revenue: 65949000000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 702000000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 1374000000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 123000000.00
AXP.TO balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 123000000.00
AXP.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: -564000000.00
AXP.TO income_statement (annual, 2024-12-31) — Other Non Interest Expense: 31765000000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Other Properties: 16914000000.00
AXP.TO balance_sheet (quarterly, 2024-12-31) — Other Properties: 16914000000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 1192000000.00
AXP.TO balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 1192000000.00
AXP.TO income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 76000000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Payables: 15270000000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 17391000000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Preferred Shares Number: 1600000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
AXP.TO income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 58000000.00
AXP.TO income_statement (annual, 2024-12-31) — Pretax Income: 12895000000.00
AXP.TO income_statement (annual, 2024-12-31) — Professional Expense And Contract Services Expense: 2274000000.00
AXP.TO cash_flow (annual, 2024-12-31) — Purchase Of Business: -454000000.00
AXP.TO cash_flow (quarterly, 2024-12-31) — Purchase Of Business: -364000000.00
AXP.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -1593000000.00
AXP.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1911000000.00
AXP.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1676000000.00
AXP.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -10759000000.00
AXP.TO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -6020000000.00
AXP.TO income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 123000000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: 22148000000.00
AXP.TO income_statement (annual, 2024-12-31) — Salaries And Wages: 8198000000.00
AXP.TO cash_flow (annual, 2024-12-31) — Sale Of Business: 594000000.00
AXP.TO cash_flow (quarterly, 2024-12-31) — Sale Of Business: 0.00
AXP.TO cash_flow (annual, 2024-12-31) — Sale Of Investment: 2221000000.00
AXP.TO income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 6040000000.00
AXP.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 14238000000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Share Issued: 702000000.00
AXP.TO income_statement (annual, 2024-12-31) — Special Income Charges: 408000000.00
AXP.TO income_statement (quarterly, 2024-12-31) — Special Income Charges: -123000000.00
AXP.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 504000000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 30264000000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 25954000000.00
AXP.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 87516711.90
AXP.TO income_statement (annual, 2024-12-31) — Tax Provision: 2766000000.00
AXP.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
AXP.TO balance_sheet (annual, 2024-12-31) — Total Assets: 271461000000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 79979000000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Total Debt: 51089000000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 30264000000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 241197000000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 1386000000.00
AXP.TO balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 1386000000.00
AXP.TO income_statement (annual, 2024-12-31) — Total Unusual Items: 408000000.00
AXP.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items: -123000000.00
AXP.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 408000000.00
AXP.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -123000000.00
AXP.TO balance_sheet (annual, 2024-12-31) — Unrealized Gain Loss: -9000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 16967000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 13564000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -11130000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 11037000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 1110000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 10787644223.00
AXP.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.24
AXP.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 40640000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -430000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 140000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 52406000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 52508000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -509000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 173000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Cash Financial: 3010000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 6643000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 451000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 4764000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 228000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 18000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Change In Payable: 228000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 228000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 246000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: 11858000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 140000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -509000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 31202000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 22000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -1208000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Current Debt: 1559000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1559000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -20000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: -20000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 433000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 433000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 10803033159.00
AXP.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.24
AXP.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 2552000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 10000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 52508000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 6643000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Foreign Currency Translation Adjustments: -2907000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 4334000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -3366000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 2120000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 16513000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 1966000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Interest Income: 6135000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 83997000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 451000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 1110000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 22000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 4899000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 51236000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 51236000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 4768000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -3534000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Minimum Pension Liabilities: -453000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -1186000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Net Debt: 389000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Net Income: 2584000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 2552000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 2584000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 2584000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 2584000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 2584000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 2584000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: 4169000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 46000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 1365000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 1234000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 5383000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -430000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 131000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 31202000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 2584000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 4764000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 16967000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 701109524.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 1559000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 213000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Other Non Interest Expense: 8340000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 18000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Payables: 13564000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 13564000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Preferred Shares Number: 1600000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
AXP.TO income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 14000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 3330000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Professional Expense And Contract Services Expense: 541000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -239000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -430000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 433000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -3534000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -1208000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 23391000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 2120000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 285000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 1486000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 3606000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 701109524.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 131000000.00
AXP.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 158000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 31202000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 31202000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
AXP.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 746000000.00
AXP.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.22
AXP.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 282244000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 82438000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 52795000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 31202000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 251042000000.00
AXP.TO balance_sheet (quarterly, 2025-03-31) — Unrealized Gain Loss: -6000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 17856000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 14121000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -11369000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 11052000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 270000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 10741477415.00
AXP.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.27
AXP.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 52508000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -619000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 140000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 57830000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 57937000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -593000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 101000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Cash Financial: 3109000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 7678000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -6797000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 4364000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 1207000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -1170000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Change In Payable: 1207000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 1207000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 37000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 5245000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 140000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -593000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 32311000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -1356000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Current Debt: 1493000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1493000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -365000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: -365000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 427000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 427000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 10756866351.00
AXP.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.27
AXP.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 2852000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 184000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 57937000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 7678000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Foreign Currency Translation Adjustments: -2792000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 3745000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Business: 0.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -3248000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 2152000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 17031000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 2077000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Interest Income: 6264000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 92006000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -6797000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 1258000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 11018000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 58202000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 58202000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 11128000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -4361000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Minimum Pension Liabilities: -450000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -633000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -1356000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 1865000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Net Income: 2885000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 2852000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 2885000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 2885000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 2885000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 2885000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 2885000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: 4187000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -227000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 6657000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 6767000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 5662000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -619000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -110000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 32311000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 2885000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 4364000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 17856000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 696000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 1493000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -152000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 8603000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 988000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 18000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Payables: 14121000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 14121000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Preferred Shares Number: 1600000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
AXP.TO income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 15000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 3550000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Professional Expense And Contract Services Expense: 591000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -530000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -619000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 427000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -4361000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -1356000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 24367000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Salaries And Wages: 2152000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 303000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 1555000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 3707000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 696000000.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: -110000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
AXP.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 127000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 32311000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 32311000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
AXP.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 665000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.19
AXP.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 295556000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 90513000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 59695000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 32311000000.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 263245000000.00
AXP.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
AXP.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
AXP.TO balance_sheet (quarterly, 2025-06-30) — Unrealized Gain Loss: -6000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 18426000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 14708000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -11754000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 11059000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 235000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 57937000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -655000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 138000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 53468000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 54706000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -586000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 38000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Cash Financial: 3229000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -2957000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -6598000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 6233000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 1889000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -181000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Change In Payable: 1889000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1889000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1708000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -3322000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 138000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 32417000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 26000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -2351000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Current Debt: 1446000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1446000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -257000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: -257000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 455000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 455000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 2868000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 91000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 54706000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -2957000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Foreign Currency Translation Adjustments: -2798000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 5578000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: 0.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -3249000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 2239000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 17615000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 2131000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Interest Income: 6617000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 91650000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -6598000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 1374000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 26000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 6459000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 57787000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 57787000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 6479000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -7001000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Minimum Pension Liabilities: -446000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -2325000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Net Debt: 5765000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Net Income: 2902000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 2868000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 2902000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 2902000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 2902000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 2902000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 2902000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: 4486000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -215000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -542000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -522000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 5861000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -654000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -20000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 32417000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 2902000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Occupancy And Equipment: 751000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 6233000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 18426000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 689000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 1446000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 13000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 8102000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 1139000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 20000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Payables: 14708000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 14708000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Preferred Shares Number: 1600000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
AXP.TO income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 14000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 3825000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Professional Expense And Contract Services Expense: 623000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -545000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -655000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 455000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -7001000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -2351000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 24469000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Salaries And Wages: 2239000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Sale Of Business: 0.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 330000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 1000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 1599000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 3838000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 689000000.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: -20000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
AXP.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 125000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 32417000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 32417000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
AXP.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 923000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.24
AXP.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 297550000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 90204000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 59233000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 32417000000.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 265133000000.00
AXP.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
AXP.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
AXP.TO balance_sheet (quarterly, 2025-09-30) — Unrealized Gain Loss: -5000000.00
AXP.TO income_statement (annual, 2025-12-31) — +Total Revenue: 72230000000.00
AXP.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 18981000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 14700000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 14700000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -12039000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -12039000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 11126000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 11126000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 217000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 217000000.00
AXP.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 10695310606.00
AXP.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 10572199117.00
AXP.TO income_statement (annual, 2025-12-31) — Basic EPS: 1.00
AXP.TO income_statement (quarterly, 2025-12-31) — Basic EPS: 0.23
AXP.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 40640000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 54706000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -2425000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -721000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 138000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 138000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 47708000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 47708000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 47792000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 47792000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -2271000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -583000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Cash Equivalents: 658000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 658000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Cash Financial: 3559000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Cash Financial: 3559000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 11210000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -154000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -22891000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -9947000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 18428000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 3067000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Change In Account Payable: 3645000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 321000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -2781000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -1448000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Change In Payable: 3645000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Change In Payable: 321000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 3645000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 321000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: 864000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -1127000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Changes In Cash: 6747000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -7034000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Common Stock: 138000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 138000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -2271000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 33474000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 33474000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 57000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 9000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: -5814000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -899000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 2247000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 2247000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Current Debt: 1371000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 1371000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1371000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1371000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: -542000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 100000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Deferred Tax: -542000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: 100000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1777000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 462000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1777000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 462000000.00
AXP.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 10710699543.00
AXP.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 10587588054.00
AXP.TO income_statement (annual, 2025-12-31) — Diluted EPS: 1.00
AXP.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.23
AXP.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 10701000000.00
AXP.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 2429000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 405000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 120000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Employee Benefits: 3091000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 3091000000.00
AXP.TO cash_flow (annual, 2025-12-31) — End Cash Position: 47792000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 47792000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 11210000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -154000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: -2783000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: -2783000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 16003000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 2346000000.00
AXP.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Business: 0.00
AXP.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Business: 0.00
AXP.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -3277000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -3277000000.00
AXP.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 9016000000.00
AXP.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 2505000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Goodwill: 4873000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Goodwill: 4873000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 4963000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 4963000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 19155000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 19155000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Income Tax Payable: 1401000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 1401000000.00
AXP.TO income_statement (annual, 2025-12-31) — Interest Expense: 8234000000.00
AXP.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 2060000000.00
AXP.TO income_statement (annual, 2025-12-31) — Interest Income: 25598000000.00
AXP.TO income_statement (quarterly, 2025-12-31) — Interest Income: 6582000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 91233000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 91233000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -22891000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -9947000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Investments And Advances: 1043000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 1043000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 57000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 9000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 24377000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 2001000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Long Term Debt: 56388000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 56388000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 56388000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 56388000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 24377000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 2002000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -18157000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -3261000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Minimum Pension Liabilities: -490000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Minimum Pension Liabilities: -490000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -633000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
AXP.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -5757000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -890000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Net Debt: 10051000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 10051000000.00
AXP.TO income_statement (annual, 2025-12-31) — Net Income: 10833000000.00
AXP.TO income_statement (quarterly, 2025-12-31) — Net Income: 2462000000.00
AXP.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 10701000000.00
AXP.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 2429000000.00
AXP.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 10833000000.00
AXP.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 2462000000.00
AXP.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 10833000000.00
AXP.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2462000000.00
AXP.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 10833000000.00
AXP.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2462000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 10833000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 2462000000.00
AXP.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 10833000000.00
AXP.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 2462000000.00
AXP.TO income_statement (annual, 2025-12-31) — Net Interest Income: 17364000000.00
AXP.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: 4522000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -260000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 136000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 6193000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -1287000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 6220000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -1259000000.00
AXP.TO balance_sheet (annual, 2025-12-31) — Net PPE: 7116000000.00
AXP.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 7116000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -2425000000.00
AXP.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -722000000.00
AXP.TO cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -27000000.00